(Q76336944)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14967110%20AND%20SRC:MED&resulttype=core&format=json

23 November 2019

title

[Intervention program to improve secondary prevention of myocardial infarction. Results of the PRESENTE (early secondary prevention) study] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14967110%20AND%20SRC:MED&resulttype=core&format=json

23 November 2019

author name string

José A de Velasco

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14967110%20AND%20SRC:MED&resulttype=core&format=json

23 November 2019

Juan Cosín

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14967110%20AND%20SRC:MED&resulttype=core&format=json

23 November 2019

Manuel de Oya

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14967110%20AND%20SRC:MED&resulttype=core&format=json

23 November 2019

Eduardo de Teresa

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14967110%20AND%20SRC:MED&resulttype=core&format=json

23 November 2019

Grupo de investigadores del estudio PRESENTE

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14967110%20AND%20SRC:MED&resulttype=core&format=json

23 November 2019

publication date

1 February 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14967110%20AND%20SRC:MED&resulttype=core&format=json

Revista Española de Cardiología

23 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14967110%20AND%20SRC:MED&resulttype=core&format=json

23 November 2019

volume

57

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14967110%20AND%20SRC:MED&resulttype=core&format=json

23 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14967110%20AND%20SRC:MED&resulttype=core&format=json

23 November 2019

page(s)

146-154

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14967110%20AND%20SRC:MED&resulttype=core&format=json

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

23 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977077-3

7 January 2021

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977077-3

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977077-3

7 January 2021

Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977077-3

7 January 2021

[Guidelines of the Spanish Society of Cardiology for cardiovascular disease prevention and cardiac rehabilitation]

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977077-3

7 January 2021

Beta blockade during and after myocardial infarction: an overview of the randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977077-3

7 January 2021

Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977077-3

7 January 2021

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977077-3

7 January 2021

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977077-3

7 January 2021

[New data on secondary prevention of myocardial infarction in Spain. Results of the PREVESE II study].

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977077-3

7 January 2021

Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977077-3

7 January 2021

Use of lipid-lowering medications at discharge in patients with acute myocardial infarction: data from the National Registry of Myocardial Infarction 3.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977077-3

7 January 2021

Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977077-3

7 January 2021

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977077-3

7 January 2021

Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study)

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977077-3

7 January 2021

Early statin treatment following acute myocardial infarction and 1-year survival

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977077-3

7 January 2021

Secondary prevention in coronary heart disease: a randomised trial of nurse led clinics in primary care.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977077-3

7 January 2021

A novel telephone-based system for management of secondary prevention to a low-density lipoprotein cholesterol < or = 100 mg/dl

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977077-3

7 January 2021

Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP)

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977077-3

7 January 2021

[Variability in the in-hospital management of acute myocardial infarction in Spain. IBERICA Study (Investigación, Búsqueda Específica y Registro de Isquemia Coronaria Aguda)]

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977077-3

7 January 2021

EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. EUROASPIRE Study Group. European Action on Secondary Prevention through Intervention to Reduce Events

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977077-3

7 January 2021

Lipid-lowering therapy following major cardiac events: progress and deficits

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977077-3

7 January 2021

[Variability in the management and prognosis at short- and medium-term of myocardial infarct in Spain: the PRIAMHO study. Registration Project of Hospital Acute Myocardial Infarct]

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977077-3

7 January 2021

Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977077-3

7 January 2021

The A-to-Z Trial: Methods and rationale for a single trial investigating combined use of low-molecular-weight heparin with the glycoprotein IIb/IIIa inhibitor tirofiban and defining the efficacy of early aggressive simvastatin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977077-3

7 January 2021

Design of the Pravastatin or Atorvastatin Evaluation and Infection Therapy (PROVE IT)-TIMI 22 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2804%2977077-3

7 January 2021

10.1016/S0300-8932(04)77077-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14967110%20AND%20SRC:MED&resulttype=core&format=json

23 November 2019

1 reference